BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36997023)

  • 1. Stereotactic Body Radiation Therapy for Posterior Element-Only Spinal Metastases: A First Report on Outcomes and Validation of Recommended Clinical Target Volume Delineation Practice.
    Burgess L; Zeng KL; Myrehaug S; Soliman H; Tseng CL; Detsky J; Chen H; Moore-Palhares D; Witiw CD; Zhang B; Maralani P; Sahgal A
    Pract Radiat Oncol; 2023; 13(4):321-327. PubMed ID: 36997023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.
    Chan MW; Thibault I; Atenafu EG; Yu E; John Cho BC; Letourneau D; Lee Y; Yee A; Fehlings MG; Sahgal A
    J Neurosurg Spine; 2016 Apr; 24(4):652-9. PubMed ID: 26682603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
    Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
    J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine.
    Redmond KJ; Robertson S; Lo SS; Soltys SG; Ryu S; McNutt T; Chao ST; Yamada Y; Ghia A; Chang EL; Sheehan J; Sahgal A
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):64-74. PubMed ID: 27843035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT).
    Dunne EM; Sahgal A; Lo SS; Bergman A; Kosztyla R; Dea N; Chang EL; Chang UK; Chao ST; Faruqi S; Ghia AJ; Redmond KJ; Soltys SG; Liu MC
    Radiother Oncol; 2020 Apr; 145():21-29. PubMed ID: 31874346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
    Balagamwala EH; Angelov L; Koyfman SA; Suh JH; Reddy CA; Djemil T; Hunter GK; Xia P; Chao ST
    J Neurosurg Spine; 2012 Dec; 17(6):556-64. PubMed ID: 23020208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
    Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
    Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
    J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
    Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
    Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
    Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
    Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for spinal metastases with or without separation surgery.
    Bate BG; Khan NR; Kimball BY; Gabrick K; Weaver J
    J Neurosurg Spine; 2015 Apr; 22(4):409-15. PubMed ID: 25635638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
    Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT.
    Prins FM; van der Velden JM; Gerlich AS; Kotte ANTJ; Eppinga WSC; Kasperts N; Verlaan JJ; Pameijer FA; Kerkmeijer LGW
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S147-S154. PubMed ID: 28866897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irradiation of spinal metastases: should we continue to include one uninvolved vertebral body above and below in the radiation field?
    Klish DS; Grossman P; Allen PK; Rhines LD; Chang EL
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1495-9. PubMed ID: 21074335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.